Vasomune
<UNKNOWN> · 1 known investors
Vasomune Therapeutics develops investigational medicines, including AV-001, which has received US FDA Fast Track designation. The company focuses on therapeutic drug development in the biotech sector.
Biotech
<UNKNOWN> · 1 known investors
Vasomune Therapeutics develops investigational medicines, including AV-001, which has received US FDA Fast Track designation. The company focuses on therapeutic drug development in the biotech sector.